All lobbying filings

THE MCMANUS GROUP

Lobbying for VIVEX BIOLOGICS · Biologics Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Florida · House · Senate · $50,000.00 income · posted Jul 21, 2025

Official filing document

Lobbying activity 2

Health Issues

Education on Human Cellular Tissue Products (HCTPs).

Medicare/Medicaid

Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. Issues related to coverage, including VIA Disc local coverage determination. LCD ID: L39962 - Coverage Indications, Limitations and/or Medical Necessity section to include non-coverage for all intervertebral disc injections for management of chronic low back pain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.